Fujita Health University
Clinical trials sponsored by Fujita Health University, explained in plain language.
-
New Parkinson's combo drug enters first human safety test
Disease control Recruiting nowThis study aims to check if a combination of two existing drugs, febuxostat and inosine, is safe for people with Parkinson's disease. It will involve 24 adults with early-stage Parkinson's who will take the pills twice daily for 12 weeks. The main goal is to see how the body hand…
Phase: PHASE1 • Sponsor: Fujita Health University • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists peer inside heart attack plaques to solve diagnostic puzzle
Knowledge-focused Recruiting nowThis study aims to improve how doctors identify the specific type of plaque that causes a heart attack. Researchers will compare high-resolution artery images taken during a standard procedure with a detailed analysis of tiny tissue samples removed from the blockage. The goal is …
Sponsor: Fujita Health University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC